Doctors for Safer Drug Policy
@dsdp.ca
A group of physicians who care for people who use substances and advocate for safer, more compassionate, evidence-based healthcare policies.
We're just getting started on this report and will have more to say later.
November 17, 2025 at 12:20 AM
We're just getting started on this report and will have more to say later.
"He also said that the rise of nitazenes reflects a larger problem with unregulated drugs. “As long as it’s unregulated, there’s going to continue to be volatility in it,” he said...he stressed the importance of regulation and expanding safer supply as interventions to make substances ... safer."
November 6, 2025 at 5:19 PM
"He also said that the rise of nitazenes reflects a larger problem with unregulated drugs. “As long as it’s unregulated, there’s going to continue to be volatility in it,” he said...he stressed the importance of regulation and expanding safer supply as interventions to make substances ... safer."
"Herriot worries someone seeking a relatively low-potency opioid will end up with nitazenes instead. “It would actually worry me less if it was being sold as fentanyl."
November 6, 2025 at 5:19 PM
"Herriot worries someone seeking a relatively low-potency opioid will end up with nitazenes instead. “It would actually worry me less if it was being sold as fentanyl."
Do some of these places help people? Maybe. But we literally don't know without robust, comprehensive outcome reporting, including long-term follow-up.
As it stands, the scientific evidence is much stronger in support of Opioid Agonist Therapy and counselling delivered in community.
As it stands, the scientific evidence is much stronger in support of Opioid Agonist Therapy and counselling delivered in community.
October 28, 2025 at 9:25 PM
Do some of these places help people? Maybe. But we literally don't know without robust, comprehensive outcome reporting, including long-term follow-up.
As it stands, the scientific evidence is much stronger in support of Opioid Agonist Therapy and counselling delivered in community.
As it stands, the scientific evidence is much stronger in support of Opioid Agonist Therapy and counselling delivered in community.